When to Use Initial Triple Therapy in COPD: Adding a LAMA to ICS/LABA by Clinically Important Deterioration Assessment

When to Use Initial Triple Therapy in COPD: Adding a LAMA to ICS/LABA by Clinically Important Deterioration Assessment

Wen-Chien Cheng,1– 6 Biing-Ru Wu,1,3,5,6 Wei-Chih Liao,1,2,4,7 Chih-Yu Chen,1 Wei-Chun Chen,1,3– 6 Te-Chun Hsia,1,4,8 Chih-Yen Tu,1– 3 Chia-Hung Chen,1,2,7 Wu-Huei Hsu1 1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical Uni...

Full description

Bibliographic Details
Main Authors: Cheng WC, Wu BR, Liao WC, Chen CY, Chen WC, Hsia TC, Tu CY, Chen CH, Hsu WH
Format: Article
Language:English
Published: Dove Medical Press 2020-12-01
Series:International Journal of COPD
Subjects:
inhaled corticosteroid
ics
long-acting muscarinic antagonist
lama
long-acting β2 agonist
laba
triple therapy
chronic pulmonary obstructive disease
copd
clinically important deterioration
cid.
Online Access:https://www.dovepress.com/when-to-use-initial-triple-therapy-in-copd-adding-a-lama-to-icslaba-by-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/when-to-use-initial-triple-therapy-in-copd-adding-a-lama-to-icslaba-by-peer-reviewed-article-COPD

Similar Items